| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/17/1996 | EP0721775A2 Combination of active agents efficcient against unhealthy skin, mild acne and grampositive bacteria |
| 07/17/1996 | EP0721506A1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/17/1996 | EP0721505A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/17/1996 | EP0721465A1 Glutathione s-transferase-activated compounds |
| 07/17/1996 | EP0721457A1 2',5'-OLIGOADENYLATE-2',3'-CYCLOPHOSPHATES and 2',5'-OLIGOADENYLATES with antipapilloma virus activity |
| 07/17/1996 | EP0721347A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections |
| 07/17/1996 | EP0721342A1 The semaphorin gene family |
| 07/17/1996 | EP0721340A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 07/17/1996 | EP0721337A1 Oral formulations of an antifungal |
| 07/17/1996 | EP0721335A1 Mycophenolate mofetil high dose oral suspensions |
| 07/17/1996 | EP0721324A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
| 07/17/1996 | EP0721300A1 Substantive antimicrobial phosphates |
| 07/17/1996 | EP0711301A4 Processes and intermediates for phosphorous-containing covalent linkages |
| 07/17/1996 | EP0681470B1 Recombinant living subunit vaccine composition and process for its preparation |
| 07/17/1996 | CN1126997A Novel erythromycin derivatives, method for preparing same and use thereof as drugs |
| 07/16/1996 | US5536850 Substance DC114-A1 |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536745 (Hetero)-aryl ketones derivatives with antibacterial properties |
| 07/16/1996 | US5536729 Rapamycin formulations for oral administration |
| 07/16/1996 | US5536496 Pasteurella multocida toxoid vaccines |
| 07/11/1996 | WO1996021020A2 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996020956A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | WO1996020945A1 Novel aminooligosaccharide derivative and process for preparing the same |
| 07/11/1996 | WO1996020939A1 POLYMORPHS B AND C OF 1-[2,4-DICHLORO-β-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE |
| 07/11/1996 | WO1996020926A1 Substituted imides as tnf inhibitors |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020727A1 Chicken anaemia agent broiler vaccine |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020717A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | WO1996020711A1 Drugs to prevent recurrent herpes virus infections |
| 07/11/1996 | WO1996020708A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2209663A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | CA2208016A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2205871A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/10/1996 | EP0720988A1 Pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane |
| 07/10/1996 | EP0720987A1 Acylated pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane |
| 07/10/1996 | EP0720654A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 07/10/1996 | EP0720653A1 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720612A1 Novel substituted propane-2-ol derivatives |
| 07/10/1996 | EP0720607A1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 07/10/1996 | EP0720604A1 Conformationally locked nucleoside analogues |
| 07/10/1996 | EP0720603A1 Bis(amidinobenzimidazolyl)alkanes as antiviral agents |
| 07/10/1996 | EP0370090B1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |
| 07/10/1996 | CN1126469A HIV protease inhibitors useful for the treatment of aids |
| 07/10/1996 | CN1126438A Method of combating acyclovir-resistant herpes simplex viral infections |
| 07/10/1996 | CN1126211A Quinolone- and naphthyridonecarboxylic acid derivatives |
| 07/10/1996 | CN1032258C Process for preparacing phospholpid derivatives of nucleosides |
| 07/10/1996 | CN1032257C Process for preparing pyrroliaylthio-carbapenem derivatives |
| 07/09/1996 | US5534535 Antiviral analogs with substituted benzimidazole base |
| 07/09/1996 | US5534523 Anti-aids virus composition |
| 07/09/1996 | US5534510 2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-carbapenem derivatives |
| 07/09/1996 | US5534508 Cephem compounds and antimicrobial agents |
| 07/09/1996 | US5534411 Monoclonal IgA antibody specific for respiratory syncytial virus, a hybridoma cell line that produces this antibody amd methods of using the antibody to diagnose RSV infection |
| 07/09/1996 | US5534257 Genetic engineering; insertion of foreign peptide epitope; vaccines |
| 07/09/1996 | US5534256 Vaccines, veterinary medicine |
| 07/09/1996 | US5534253 Gentamycin |
| 07/09/1996 | CA2073601C Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
| 07/09/1996 | CA1338441C Expression of immunologically active proteins of human .beta.-lympho tropic virus |
| 07/09/1996 | CA1338439C Controlled release formulations of tetracycline compounds |
| 07/05/1996 | CA2166374A1 Acylated pseudopeptides containing a trifluoromethyl-substituted 2-azabicyclooctane |
| 07/05/1996 | CA2166372A1 Pseudopeptides having a trifluoromethyl-substituted 2-azabicyclooctane |
| 07/04/1996 | WO1996020273A1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020199A2 Diclavulanate salt with a diamino ether and process of preparation |
| 07/04/1996 | WO1996020198A1 Production of cefotaxime and new sodium salts |
| 07/04/1996 | WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof |
| 07/04/1996 | WO1996020184A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | WO1996020180A1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
| 07/04/1996 | WO1996020171A1 Antiherpes peptidomimetic compounds |
| 07/04/1996 | WO1996019972A1 Low rigidity liposomal antibacterial composition |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2207772A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | CA2207548A1 Piperazine 2,5-dione derivatives as modulators of multi-drug resistance |
| 07/04/1996 | CA2206518A1 Production of cefotaxime and new sodium salts |
| 07/03/1996 | EP0719864A2 Recombinant live avian vaccin, using an avian herpes virus as vector |
| 07/03/1996 | EP0719861A1 Nucleic sequences from the genome of Salmonella Typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 07/03/1996 | EP0719860A1 Compositions and method for treating or preventing infections in animals |
| 07/03/1996 | EP0719778A1 Diamine salts of clavulanic acid |
| 07/03/1996 | EP0719777A2 N-oxotetrahydro-beta-carbolines |
| 07/03/1996 | EP0719560A1 Antibordetella acellular vaccine |
| 07/03/1996 | EP0719550A2 A method of inhibiting endotoxin induced effects |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719336A1 Modified plant viruses as vectors of heterologous peptides |
| 07/03/1996 | EP0719334A1 Pharmaceutical compositions containing ecotin and homologs thereof |
| 07/03/1996 | EP0719285A1 Il8 inhibitors |
| 07/03/1996 | EP0719274A1 Method for dosing therapeutic compounds |
| 07/03/1996 | EP0719273A1 Nucleotide analogs |
| 07/03/1996 | EP0719267A1 Second messenger cell signaling inhibitors |
| 07/03/1996 | EP0719255A1 Substituted pyridines, process for producing them and their use as pesticides and fungicides |
| 07/03/1996 | EP0719245A1 Novel compounds |
| 07/03/1996 | EP0719155A1 $i(CAMPYLOBACTER JEJUNI) ANTIGENS, AND METHODS FOR THEIR PRODUCTION AND USE |
| 07/03/1996 | EP0719142A1 Pharmaceutical composition of hiv-protease inhibitors |
| 07/03/1996 | EP0719137A1 Viscous surfactant emulsion compositions |
| 07/03/1996 | CN1125947A Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 07/03/1996 | CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |